(Q35573912)

8 August 2017

1 reference

title

Autoimmune overlapping syndromes (English)

1 reference

8 August 2017

1

Raoul Poupon

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14594134

27 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1089326103000928?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00092-8

https://api.elsevier.com/content/article/PII:S1089326103000928?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00092-8

27 March 2024

published in

Clinics in liver disease

1 reference

8 August 2017

volume

7

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

865-878

1 reference

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Non-organ specific autoantibodies in children with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Immunologic features and HLA associations in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antimitochondrial antibodies in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Diagnosis and treatment of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Current and novel immunosuppressive therapy for autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Azathioprine for long-term maintenance of remission in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Recurrence of autoimmune hepatitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Liver transplantation for autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Response to steroids in de novo autoimmune hepatitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune hepatitis with incidental histologic features of bile duct injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Granulomas in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Natural history of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Small-duct primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Current concepts in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity!

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Autoimmune overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

A 28-year-old woman with a combined hepatitic/cholestatic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Bile acids regulate RANTES gene expression through its cognate NF-kappaB binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900092-8

7 January 2021

Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease

series ordinal

36

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00092-8

Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis

27 March 2024

series ordinal

54

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00092-8

Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome

27 March 2024

series ordinal

79

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00092-8

27 March 2024

Identifiers

1 reference

8 August 2017

1 reference